trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['t-dxd', 'lung', 'nsclc', 'sclc', 'trastuzumab deruxtecan']
for more, listen to this episode of the podcast, lung cancer considered, to hear drs. and discuss trastuzumab deruxtecan (t-dxd) in #her2 nsclc (references older dose, not this new data). #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him